People Increasingly Prescribed Levothyroxine for Subclinical Hypothyroidism (FREE)
By Kelly Young
Prescriptions for levothyroxine have increased markedly since 2002, and many people are potentially being overtreated for subclinical hypothyroidism, according to a JAMA Internal Medicine study. U.K. researchers retrospectively assessed thyrotropin levels among some … (Source: Physician's First Watch current issue)
Source: Physician's First Watch current issue - October 8, 2013 Category: Primary Care Source Type: news
U.K. Docs Treat More Thyroid Disease
(MedPage Today) -- Clinicians in the U.K. have been treating more moderate degrees of hypothyroidism with levothyroxine (Synthroid), raising questions about risks and benefits, researchers found. (Source: MedPage Today Endocrinology)
Source: MedPage Today Endocrinology - October 7, 2013 Category: Endocrinology Source Type: news
Study Opens Door For Additional Treatment Option For Hypothyroidism
Desiccated thyroid extract (DTE), derived from crushed preparations of animal thyroid glands, is a safe and effective alternative to standard T4 therapy in hypothyroid patients, a new study finds. The results were presented at The Endocrine Society's 95th Annual Meeting in San Francisco. In adults, untreated hypothyroidism leads to poor mental and physical performance. It also can cause high blood cholesterol levels that can lead to heart disease. The condition is treated with Levothyroxine, a synthetic (laboratory-made) form of T4 that is identical to the T4 the thyroid naturally makes... (Source: Health News from Medical News Today)
Source: Health News from Medical News Today - June 18, 2013 Category: Consumer Health News Tags: Endocrinology Source Type: news
levothyroxine sodium, Synthroid, Levoxyl, Levothroid, Unithroid, Tirosint, Levo-T
Title: levothyroxine sodium, Synthroid, Levoxyl, Levothroid, Unithroid, Tirosint, Levo-TCategory: MedicationsCreated: 12/31/1997 12:00:00 AMLast Editorial Review: 3/27/2013 12:00:00 AM (Source: MedicineNet Thyroid General)
Source: MedicineNet Thyroid General - March 27, 2013 Category: Endocrinology Source Type: news
MHRA publishes a report on levothyroxine tablet products: A review of the clinical and quality considerations
Source: MHRA
Area: News
In response to concerns expressed by patients and healthcare professionals regarding potential inconsistencies in the quality and effectiveness of levothyroxine products, the MHRA has conducted and published a review. Recommendations from this review were endorsed in March 2012 by the Commission on Human Medicines, an independent panel of experts who advise the licensing authority.
The review stated that levothyroxine tablets are difficult to manufacture and may be prone to instability once formulated. However, tighter controls on the quality of the tablet in the form of a d...
Source: NeLM - News - January 8, 2013 Category: Drugs & Pharmacology Source Type: news
Are generic and branded L-thyroxine really bioequivalent?
NEW YORK (Reuters Health) - Generic and brand-name levothyroxine are not bioequivalent for children
with severe congenital hypothyroidism, caution researchers from Boston Children's Hospital and Harvard Medical
School. (Source: Modern Medicine)
Source: Modern Medicine - January 7, 2013 Category: Journals (General) Source Type: news
